Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai(University of California, San Francisco), John Huang(University of California, San Francisco), Xiaoqing Lu(AbbVie (United States)), Donald M. Simons(AbbVie (United States)), Chanhyuk Park(University of California, San Francisco), Anthony Chang(University of California, San Francisco), Whitney Tamaki(University of California, San Francisco), Eric Liu(University of California, San Francisco), Kole T. Roybal(University of California, San Francisco), Jane Seagal(AbbVie (United States)), Mingyi Chen(The University of Texas Southwestern Medical Center), Katsunobu Hagihara(University of California, San Francisco), Xiao X. Wei(University of California, San Francisco), Michel DuPage(University of California, San Francisco), Serena S. Kwek(University of California, San Francisco), David Y. Oh(University of California, San Francisco), Adil Daud(University of California, San Francisco), Katy K. Tsai(University of California, San Francisco), Clint Wu(University of California, San Francisco), Li Zhang(University of California, San Francisco), Marcella Fassò(University of California, San Francisco), Ravi Sachidanandam, Anitha D. Jayaprakash, Ingrid Lin(University of California, San Francisco), Amy-Jo Casbon(University of California, San Francisco), Gillian A. Kinsbury(AbbVie (United States)), Lawrence Fong(University of California, San Francisco)
Cited by 134